维普期刊资源整合服务平台（V6.5）

70篇 您的检索式：作者名="Sima CS"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Association of kras and egfr mutations with survival in patients with advanced lung adenocarcinomas显示文摘	Johnson ML Sima CS Chaft J	2013	Cancer2013，119，：	1
2	Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer:Distinct natural history of patients with tumors harboring the T790M mutation显示文摘	Oxnard GR Arcila ME Sima CS		0，，06：	1
3	Vascular endothelium in atherosclerosis显示文摘	Sima AV Stancu CS Simionescu M	2009	Cell and Tissue Research2009，335，1：	1
4	The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality 显示文摘	Schaubel DE Sima CS Goodrich NP	2008	Am J Transplant2008，8，2：	1
5	Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to Erlotinib or Gefitinib:Implications for clinical trial design显示文摘	Chaft JE Oxnard GR Sima CS		0，，19：	1
6	Response to erlotinib in patients with EGFR mutant advanced non-small cell lung cancers with a squamous or squamous-like component显示文摘	Paik PK Varghese AM Sima CS	2012	Mol Cancer Ther2012，11，：	1
7	The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality显示文摘	Sehaubel DE Sima CS Goodrich NP		0，，02：	1
8	Vascular endothelium in atherosclerosis显示文摘	Sima AV Stancu CS Simionescu M	2009	Cell Tissue Res2009，335，：	1
9	Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib:implications for clinical trial design显示文摘	Chaft JE Oxnard GR Sima CS		0，，19：	1
10	Clinical impact of immune in stage I lung adenocarcinoma: Tumor inter- leukin-12 receptor beta2 ( IL-12Rbeta2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence 显示文摘	Suzuki K Kadota K Sima CS	2013	J Clin Oncol2013，31，4：	1
11	Nomogram to predict the presence of EGFR activating mutation in lung adenoeareinoma显示文摘	Girard N Sima CS Jackman DM	2012	Eur Respir J2012，39，2：	1
12	Vascular endotheli- um in atherosclerosis显示文摘	Sima AV Stancu CS Simionescu M	2009	Cell Tissue Res2009，335，19：	1
13	Use of high technology imaging for surveillance of early stage breast cancer显示文摘	Panageas KS Sima CS Liberman L	2012	Breast Cancer Res Treat2012，131，2：	1
14	Clinical impact of immune micro-environment in stage I lung adenocareinoma: tumor interleukin - 12 re- ceptor 132 (IL - 12R132 ), IL -7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence显示文摘	Suzuki K Kadota K Sima CS	2013	J Clin Oneol2013，31，4：	1
15	A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors显示文摘	Sica G Yoshizawa A Sima CS	2010	Am J Surg Pathol2010，34，8：	1
16	Vascular endothelium inatherosclerosis显示文摘	Sima AV Stancu CS Simionescu M	2009	Cell Tissue Res2009，335，1：	1
17	Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage ⅢC ovarian cancer显示文摘	Zivanovic O Sima CS Iasonos A	2009	Gynecol Oncol2009，115，：	1
18	Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib: implications for clinical trial design显示文摘	Chaft jE Oxnard GR Sima CS	2011	Clin Cancer Res2011，17，19：	1
19	Vascular endothelium in ath- erosclerosis显示文摘	Sima AV Stancu CS Simionescu M	2009	Cell Tissue Res2009，335，1：	1
20	Immunohistochemieal algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens 显示文摘	Rekhtman N Ang DC Sima CS	2011	Mod Pathol2011，24，10：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示